Nurulimab (Anti-CTLA-4 / CD152)
A2859
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameNurulimab (Anti-CTLA-4 / CD152)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionNurulimab (Anti-CTLA-4 / CD152) is a monoclonal antibody directed against the human T-cell-expressed receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4, CTLA-4), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 145.34 KD.
- Storage Instruction-20°C
- UNSPSC12352203